Cargando…

Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking

Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring (CGM) in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) who are treated with intensive insulin regimens. Based on this evidence, CGM is now a standard of care for individuals within these diab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aleppo, Grazia, Hirsch, Irl B., Parkin, Christopher G., McGill, Janet, Galindo, Rodolfo, Kruger, Davida F., Levy, Carol J., Forlenza, Gregory P., Umpierrez, Guillermo E., Grunberger, George, Bergenstal, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mary Ann Liebert, Inc., publishers 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611973/ https://www.ncbi.nlm.nih.gov/pubmed/37471068 http://dx.doi.org/10.1089/dia.2023.0268

Ejemplares similares

Lost in Translation: A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion
por: Aleppo, Grazia, et al.
Publicado: (2021)

What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring
por: Galindo, Rodolfo J., et al.
Publicado: (2021)

Real-World Evidence Supporting Tandem Control-IQ Hybrid Closed-Loop Success in the Medicare and Medicaid Type 1 and Type 2 Diabetes Populations
por: Forlenza, Gregory P., et al.
Publicado: (2022)

A Practical Approach to Using Trend Arrows on the Dexcom G5 CGM System for the Management of Adults With Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

Optimizing Postprandial Glucose Management in Adults With Insulin-Requiring Diabetes: Report and Recommendations
por: Leahy, John (Jack) L, et al.
Publicado: (2019)

The Health Impact of Intensive and Nonintensive Grandchild Care in Europe: New Evidence From SHARE
por: Di Gessa, Giorgio, et al.
Publicado: (2016)

The Effect of Discontinuing Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Basal Insulin
por: Aleppo, Grazia, et al.
Publicado: (2021)

Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A(1c) Levels in T1D Exchange Clinic Registry Participants
por: Miller, Kellee M., et al.
Publicado: (2013)

Arterial Pressure Management in a Reconstructive Microsurgery Patients by Dopamine Infusion in a Nonintensive Care Ward
por: Martellani, Linda, et al.
Publicado: (2016)

REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes
por: Aleppo, Grazia, et al.
Publicado: (2017)

Ion channel inhibition with amiodarone or verapamil in symptomatic hospitalized nonintensive-care COVID-19 patients: The RECOVERY-SIRIO randomized trial
por: Navarese, Eliano P., et al.
Publicado: (2022)

Current Eligibility Requirements for CGM Coverage Are Harmful, Costly, and Unjustified
por: Anderson, John E., et al.
Publicado: (2020)

Deep vein thrombosis in noncritically ill patients with coronavirus disease 2019 pneumonia: deep vein thrombosis in nonintensive care unit patients
por: Jimenez-Guiu, Xavier, et al.
Publicado: (2021)

Prediction of Unbound Vancomycin Levels in Intensive Care Unit and Nonintensive Care Unit Patients: Total Bilirubin May Play an Important Role
por: Li, Xiao, et al.
Publicado: (2021)

Nudging policymakers on gendered impacts of policy
por: Bochon, Lindsay Blair, et al.
Publicado: (2023)

Improving maternal and child health policymaking processes in Nigeria: an assessment of policymakers’ needs, barriers and facilitators of evidence-informed policymaking
por: Uneke, Chigozie J., et al.
Publicado: (2017)

Flash CGM Is Associated With Reduced Diabetes Events and Hospitalizations in Insulin-Treated Type 2 Diabetes
por: Bergenstal, Richard M, et al.
Publicado: (2021)

Views of health system policymakers on the role of research in health policymaking in Israel
por: Ellen, Moriah E., et al.
Publicado: (2016)

Policymakers’ Research Capacities, Engagement, and Use of Research in Public Health Policymaking
por: Loncarevic, Natasa, et al.
Publicado: (2021)

Safety and Efficacy of Inpatient Diabetes Management with Non-insulin Agents: an Overview of International Practices
por: Galindo, Rodolfo J., et al.
Publicado: (2022)

Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
por: Brown, Sue A., et al.
Publicado: (2021)

The challenges of nutrition policymaking
por: Slavin, Joanne L
Publicado: (2015)

ABCC8-Related Monogenic Diabetes Presenting Like Type 1 Diabetes in an Adolescent
por: Grier, Alexandra E., et al.
Publicado: (2023)

Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring
por: Bergenstal, Richard M., et al.
Publicado: (2018)

Response to Comment on Bergenstal et al. Glucose Management Indicator (GMI): A New Term for Estimating A1C From Continuous Glucose Monitoring. Diabetes Care 2018;41:2275–2280
por: Bergenstal, Richard M., et al.
Publicado: (2019)

Efficacy and Safety of Technosphere Inhaled Insulin Compared With Technosphere Powder Placebo in Insulin-Naive Type 2 Diabetes Suboptimally Controlled With Oral Agents
por: Rosenstock, Julio, et al.
Publicado: (2008)

Case-control Investigation of Previously Undiagnosed Diabetes in the Critically Ill
por: Krinsley, James S, et al.
Publicado: (2022)

Comprehensive Telehealth Model to Support Diabetes Self-Management
por: Aleppo, Grazia, et al.
Publicado: (2023)

Global policymakers and catastrophic risk
por: Nathan, Christopher, et al.
Publicado: (2021)

Recursive expectations approach in policymaking
por: Kobayashi, Keiichiro
Publicado: (2023)

Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice
por: Wysham, Carol H, et al.
Publicado: (2021)

SUPPORT Tools for evidence-informed health Policymaking (STP) 1: What is evidence-informed policymaking?
por: Oxman, Andrew D, et al.
Publicado: (2009)

SUPPORT Tools for evidence-informed health Policymaking (STP) 15: Engaging the public in evidence-informed policymaking
por: Oxman, Andrew D, et al.
Publicado: (2009)

Enhancing health policymakers' information literacy knowledge and skill for policymaking on control of infectious diseases of poverty in Nigeria
por: Uneke, Chigozie Jesse, et al.
Publicado: (2015)

Promoting the use of evidence in health policymaking in the ECOWAS region: the development and contextualization of an evidence-based policymaking guidance
por: Uneke, Chigozie Jesse, et al.
Publicado: (2020)

How COVID-19 affects the use of evidence informed policymaking among iranian health policymakers and managers
por: Bastani, Peivand, et al.
Publicado: (2022)

Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications
por: Wysham, Carol H., et al.
Publicado: (2018)

A systems-based approach to policymaking
por: Greene, Kenyon
Publicado: (1993)

The human dimension of good economic policymaking()
por: Harper AO, Ian R., et al.
Publicado: (2020)

Rational policymaking during a pandemic
por: Berger, Loïc, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5ecj441r902v4pgtarf3n1pbt